References
Ahles, T.A., & Saykin, A. (2001). Cognitive effects of standard-dose chemotherapy in patients with cancer. Cancer Investigation, 19(8), 812-820.
American Cancer Society. (2007). Breast cancer facts and figures, 2007-2008. Atlanta, GA: Author.
Badger, T.A., Braden, C.J., Mishel, M.H., & Longman, A. (2004). Depression burden, psychological adjustment, and quality of life in women with breast cancer: Patterns over time. Research in Nursing and Health, 27(1), 19-28.
Baquet, C.R., & Commiskey, P. (2000). Socioeconomic factors and breast carcinoma in multicultural women. Cancer, 88(5, Suppl.), 1256-1264.
Brezden, C.B., Phillips, K.A., Abdolell, M., Bunston, T., & Tannock, I.F. (2000). Cognitive function in breast cancer patients receiving adjuvant chemotherapy. Journal of Clinical Oncology, 18(14), 2695-2701.
Broeckel, J.A., Jacobsen, P.B., Balducci, L., Horton, J., & Lyman, G.H. (2000). Quality of life after adjuvant chemotherapy for breast cancer. Breast Cancer Research and Treatment, 62(2), 141-150.
Campbell, A., Converse, P.E., & Rodgers, W.L. (1976). The quality of American life: Perceptions, evolutions, and satisfactions. New York: Russell Sage Foundation.
Cappiello, M., Cunningham, R.S., Knobf, M.T., & Erdos, D. (2007). Breast cancer survivors: Information and support after treatment. Clinical Nursing Research, 16(4), 278-293.
Castellon, S.A., Ganz, P.A., Bower, J.E., Petersen, L., Abraham, L., & Greendale, G.A. (2004). Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. Journal of Clinical and Experimental Neuropsychology, 26(7), 955-969.
Cella, D. (1998). Factors influencing quality of life in cancer patients: Anemia and fatigue. Seminars in Oncology, 25(3, Suppl. 7), 43-46.
Cimprich, B. (1992). Attentional fatigue following breast cancer surgery. Research in Nursing and Health, 15(3), 199-207.
Cimprich, B., So, H., Ronis, D.L., & Trask, C. (2005). Pre-treatment factors related to cognitive functioning in women newly diagnosed with breast cancer. Psycho-Oncology, 14(1), 70-78.
Cull, A., Hay, C., Love, S.B., Mackie, M., Smets, E., & Stewart, M. (1996). What do cancer patients mean when they complain of concentration and memory problems? British Journal of Cancer, 74(10), 1674-1679.
Cutajar, R., Ferriani, E., Scandellari, C., Sabattini, L., Trocino, C., Marchello, L.P., et al. (2000). Cognitive function and quality of life in multiple sclerosis patients. Journal of NeuroVirology, 6(Suppl. 2), S186-S190.
Farmer, B.J., & Smith, E.D. (2002). Breast cancer survivorship: Are African American women considered? A concept analysis. Oncology Nursing Forum, 29(5), 779-787.
Ferguson, R.J., Ahles, T.A., Saykin, A.J., McDonald, B.C., Furstenberg, C.T., Cole, B.F., et al. (2007). Cognitive-behavioral management of chemotherapy-related cognitive change. Psycho-Oncology, 16(8), 772-777.
Ferguson, R.J., McDonald, B.C., Saykin, A.J., & Ahles, T.A. (2007). Brain structure and function differences in monozygotic twins: Possible effects of breast cancer chemotherapy. Journal of Clinical Oncology, 25(25), 3866-3870.
Ferrell, B.R., & Dow, K.H. (1997). Quality of life among long-term cancer survivors. Oncology, 11(4), 565-575.
Ferrell, B.R., Dow, K.H., & Grant, M. (1995). Measurement of the quality of life in cancer survivors. Quality of Life Research, 4(6), 523-531.
Ferrell, B.R., Dow, K.H., Leigh, S., Ly, J., & Gulasekaram, P. (1995). Quality of life in long-term cancer survivors. Oncology Nursing Forum, 22(6), 915-922.
Fowler, C., & Baas, L.S. (2006). Illness representations in patients with chronic kidney disease on maintenance hemodialysis. Nephrology Nursing Journal, 33(2), 173-186.
Graziano, F., Bisonni, R., Catalano, V., Silva, R., Rovidati, S., Mencarini, E., et al. (2002). Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in nonanaemic cancer patients. British Journal of Cancer, 86(12), 1854-1857.
Hann, D., Winter, K., & Jacobsen, P. (1999). Measurement of depressive symptoms in cancer patients: Evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). Journal of Psychosomatic Research, 46(5), 437-443.
Harder, H., Cornelissen, J.J., Van Gool, A.R., Duivenvoorden, H.J., Eijkenboom, W.M., & van den Bent, M.J. (2002). Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation. Cancer, 95(1), 183-192.
Hess, L.M., & Insel, K.C. (2007). Chemotherapy-related change in cognitive function: A conceptual model. Oncology Nursing Forum, 34(5), 981-994.
Janardhan, V., & Bakshi, R. (2000). Quality of life and its relationship to brain lesions and atrophy on magnetic resonance images in 60 patients with multiple sclerosis. Archives of Neurology, 57(10), 1485-1491.
Jenkins, V., Shilling, V., Deutsch, G., Bloomfield, D., Morris, R., Allan, S., et al. (2006). A three-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. British Journal of Cancer, 94(6), 828-834.
Jenkins, V., Shilling, V., Fallowfield, L., Howell, A., & Hutton, S. (2004). Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study. Psycho-Oncology, 13(1), 61-66.
Lezak, M.D., Howieson, D.B., & Loring, D.W. (2004). Neuropsychological assessment (4th ed.). New York: Oxford University Press.
Longman, A.J., Braden, C.J., & Mishel, M.H. (1999). Side-effects burden, psychological adjustment, and life quality in women with breast cancer: Patterns of association over time. Oncology Nursing Forum, 26(5), 909-915.
Mallinson, T., Cella, D., Cashy, J., & Holzner, B. (2006). Giving meaning to measure: Linking self-reported fatigue and function to performance of everyday activities. Journal of Pain and Symptom Management, 31(3), 229-241.
McHorney, C.A., Ware, J.E., Jr., Rogers, W., Raczek, A.E., & Lu, J.F. (1992). The validity and relative precision of MOS short- and long-form health status scales and Dartmouth COOP charts. Results from the Medical Outcomes Study. Medical Care, 30(5, Suppl.), MS253-MS265.
Mehnert, A., Scherwath, A., Schirmer, L., Schleimer, B., Petersen, C., Schulz-Kindermann, F., et al. (2007). The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy. Patient Education and Counseling, 66(1), 108-118.
Meyers, C.A. (2000). Neurocognitive dysfunction in cancer patients. Oncology, 14(1), 75-79.
Olin, J.J. (2001). Cognitive function after systemic therapy for breast cancer. Oncology, 15(5), 613-618.
Pinto, B.M., Rabin, C., Abdow, S., & Papandonatos, G.D. (2008). A pilot study on disseminating physical activity promotion among cancer survivors: A brief report. Psycho-Oncology, 17(5), 517-521.
Posner, M.I., & Dehaene, S. (1994). Attentional networks. Trends in Neurosciences, 17(2), 75-79.
Radloff, L.S. (1977). The CES-D Scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1(3), 385-401.
Reid-Arndt, S.A. (2006). The potential for neuropsychology to inform functional outcomes research with breast cancer survivors. Neurorehabilitation, 21(1), 51-64.
Reis, L.A.G., Melbert, D., Krapcho, M., Miller, M.A., Feuer, E.J., Clegg, L., et al. (2007).
SEER cancer statistics review 1975-2004. Retrieved March 30, 2009, from
http://seer.cancer.gov/csr/1975_2005/sections.html
Russell, K.M., Von Ah, D., Honghong, Z., Hasse, J., Wagler-Ziner, K., Erpe, M., et al. African American breast cancer survivors and QOL. Manuscript submitted for publication.
Schagen, S.B., van Dam, F.S., Muller, M.J., Boogerd, W., Lindeboom, J., & Bruning, P.F. (1999). Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer, 85(3), 640-650.
Shafqat, A., Einhorn, L.H., Hanna, N., Sledge, G.W., Hanna, A., Juliar, B.E., et al. (2005). Screening studies for fatigue and laboratory correlates in cancer patients undergoing treatment. Annals of Oncology, 16(9), 1545-1550.
Stewart, A., Bielajew, C., Collins, B., Parkinson, M., & Tomiak, E. (2006). A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. Archives of Clinical Neuropsychology, 20(1), 76-89.
Taylor, J.G., Nobre, A. C. & Shapiro, K. (2006). 2006 special issue: Introduction to the special issue on brain and attention. Neural Networks, 19(9), 1321-1328.
Tchen, N., Juffs, H.G., Downie, F.P., Yi, Q.L., Hu, H., Chemerynsky, I., et al. (2003). Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. Journal of Clinical Oncology, 21(22), 4175-4183.
van Dam, F.S., Schagen, S.B., Muller, M.J., Boogerd, W., vd Wall, E., Droogleever Fortuyn, M.E., et al. (1998). Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: High-dose versus standard-dose chemotherapy. Journal of the National Cancer Institute, 90(3), 182-183.
van Wilgen, C.P., Dijkstra, P.U., Stewart, R.E., Ranchor, A.V., & Roodenburg, J.L. (2006). Measuring somatic symptoms with the CES-D to assess depression in cancer patients after treatment: Comparison among patients with oral/oropharyngeal, gynecological, colorectal, and breast cancer. Psychosomatics, 47(6), 465-470.
Yellen, S.B., Cella, D.F., Webster, K., Blendowski, C., & Kaplan, E. (1997). Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. Journal of Pain and Symptom Management, 13(2), 63-74.
Zink, A., & Niewerth, M. (2001). Numerical rating scales are methodically equivalent, but more comfortable for patients than visual analog scales [Abstract]. Arthritis and Rheumatism, 44(S9), S189.